Valley View, Ohio-based Great Lakes NeuroTechnologies (GLNT) have announced receipt of a new allowance of claims from the U.S. Patent Office focused on technology for Parkinson’s disease (PD) diagnostics and treatment. This particular patent application covers a method of measuring Parkinson’s motor symptoms such as tremor, bradykinesia, and rigidity, and…
News
California-based biotech, International Stem Cell Corporation (ISCO), will present results of its studies on a novel treatment for Parkinson’s disease during the Neuroscience 2015 Conference, Chicago. ISCO announced it will host an oral presentation at the conference, focused on the preclinical development of human parthenogenetic neural stem cells (hPNSCs) to address the neurodegenerative condition. International Stem Cell Corporation…
Researchers at the Biotech Research and Innovation Centre (BRIC), University of Copenhagen, have linked lack of signaling by the immune system-regulating cytokine Interferon-beta (IFNβ) to the on-set of non-inheritable Parkinson’s disease (PD). The research paper, entitled “Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson’s Disease-like Dementia”, was published…
Over time, levodopa and dopamine agonists’ treatment in Parkinson’s disease (PD) patients can become ineffective to control involuntary movements. Laboratory studies on PD animal models suggest that physical training may help to alleviate these symptoms offering an alternative form of therapy. Now, a research team at Universidade do Extremo Sul Catarinense in Brazil…
The Parkinson’s Disease Foundation (PDF) has recently opened applications for its eight grant programs, which will be granted to projects focused on solving, treating and ending Parkinson’s disease (PD). The foundation aims to use the research grants to support the studies of established leaders in the field, as…
In a newly published paper in the Cerebral Cortex journal entitled “Dopamine D1 Receptor-Mediated Transmission Maintains Information Flow Through the Cortico-Striato-Entopeduncular Direct Pathway to Release Movements,” researchers from Japan reported that lack of dopamine transmission through D1 receptors is linked to slower movements…
Pittsburgh, Pennsylvania based AbiliLife, a company dedicated to improving the quality of life for people with Parkinson’s, is raising money with an Indiegogo crowdfunding campaign to fund manufacture startup of its Calibrace Parkinson’s balance brace product. By supporting the campaign, contributors can improve the quality of life for people with…
In a recently published paper in Tissue Engineering Part C: Methods entitled “3D Neural Spheroid Culture: An In Vitro Model for Cortical Studies“, researchers from Brown University reported a method to produce spheres like mini-brains containing central nervous system tissue. These mini-brains have no…
Findings from a recent study published in the journal JAMDA demonstrate that antipsychotic medications increase the risk of death in patients with Parkinson’s disease psychosis (PDP). In the study entitled “Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People…
In a recently published paper in ACS Applied Materials and Interfaces journal entitled “Support of Neuronal Growth Over Glial Growth and Guidance of Optic Nerve Axons by Vertical Nanowire Arrays“, researchers from Lund University in Sweden developed a strategy to grow neuronal cells on…
Recent Posts
- New tool may identify Parkinson’s patients at risk of cognitive problems
- When Parkinson’s interrupted my uncle’s off-key shower concerts
- Trial now testing whether oral Parkinson’s med can stop tremor
- Personalized strategies may support safer mobility in Parkinson’s
- Parkinson’s makes me prioritize where I spend my energy